213 related articles for article (PubMed ID: 20727956)
1. Novel application of hot-melt extrusion for the preparation of monolithic matrices containing enteric-coated particles.
Schilling SU; McGinity JW
Int J Pharm; 2010 Nov; 400(1-2):24-31. PubMed ID: 20727956
[TBL] [Abstract][Full Text] [Related]
2. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
3. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
4. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
5. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Guan T; Wang J; Li G; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
[TBL] [Abstract][Full Text] [Related]
8. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
9. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
10. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
Terebesi I; Bodmeier R
Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
[TBL] [Abstract][Full Text] [Related]
11. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
12. Production of spherical pellets by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
[TBL] [Abstract][Full Text] [Related]
13. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
[TBL] [Abstract][Full Text] [Related]
15. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
[TBL] [Abstract][Full Text] [Related]
16. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process.
Lyons JG; Hallinan M; Kennedy JE; Devine DM; Geever LM; Blackie P; Higginbotham CL
Int J Pharm; 2007 Feb; 329(1-2):62-71. PubMed ID: 17010544
[TBL] [Abstract][Full Text] [Related]
17. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
Zheng W; Sauer D; McGinity JW
Eur J Pharm Biopharm; 2005 Jan; 59(1):147-54. PubMed ID: 15567312
[TBL] [Abstract][Full Text] [Related]
18. Production of enteric capsules by means of hot-melt extrusion.
Mehuys E; Remon JP; Vervaet C
Eur J Pharm Sci; 2005 Feb; 24(2-3):207-12. PubMed ID: 15661492
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of tablets containing enteric-coated diclofenac sodium pellets].
Qi XL; Zhu JB; Chen SJ
Yao Xue Xue Bao; 2008 Jan; 43(1):97-101. PubMed ID: 18357741
[TBL] [Abstract][Full Text] [Related]
20. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]